Model relies only on age, smoking duration, and pack-years

Early menarche, early menopause, shortened reproductive life span linked to increased risk, especially for NSCLC

Intensity-modulated radiation therapy spares more normal tissue than 3D-conformal radiotherapy

Removal of race correction was tied to a significant reduction in the estimation of lung function for African Americans

Meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy

Single-site cancer screening could save an additional 3.2 to 5.1 million life-years with perfect adherence

First-line atezolizumab monotherapy is associated with improved overall survival compared with single-agent chemotherapy

Median time to treatment was 39 days for ACCELERATE cohort versus 62 days for reference cohort using standard tissue genotyping

AUROC estimate of four-marker protein panel plus PLCO<sub>m2012</sub> was 0.88 for risk prediction of lung cancer death

Yet, variation in uptake seen by geography, race, smoking history, and age